Jones Financial Companies
PLRX icon

Jones Financial Companies’s Pliant Therapeutics PLRX Stock Holding History

Jones Financial Companies’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-200
Closed -$250 – 4340
2025
Q2 		$250 Hold
200
– – ﹤0.01% 3890
2025
Q1 		$294 Buy
200
+176
+733% +$1.07K ﹤0.01% 3562
2024
Q4 		$316 Buy
+24
New +$328 ﹤0.01% 3277

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Jones Financial Companies's PLRX Position: Q3 2025 in Review

Jones Financial Companies sold out of Pliant Therapeutics (PLRX) in Q3 2025, closing a stake of 200 shares — an estimated $250 sold.

Jones Financial Companies first reported a position in PLRX in Q4 2024 and held it in 3 quarters. The position peaked at $316 in Q4 2024. 99 funds tracked by Wall St. Rank hold PLRX as of Q3 2025.

  • Jones Financial Companies reported no remaining Pliant Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Jones Financial Companies sold 200 Pliant Therapeutics shares in Q3 2025, an estimated $250.
  • Jones Financial Companies first reported a position in Pliant Therapeutics in Q4 2024 and held it in 3 quarters.
  • Jones Financial Companies's Pliant Therapeutics position peaked at $316 in Q4 2024.
  • 99 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2025.

Based on Jones Financial Companies's 13F filing for Q3 2025, filed 4 Nov 2025.